| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/26/2008 | EP1901747A2 Pyrimidine-based cdk inhibitors for treating pain |
| 03/26/2008 | EP1901727A2 Methods for the treatment of substance abuse and dependence |
| 03/26/2008 | EP1901726A2 Composition for treatment of psychosis |
| 03/26/2008 | EP1901712A2 Therapeutic sclerosing foam made preferably xenon |
| 03/26/2008 | EP1817039A4 Treatment and prevention of epilepsy |
| 03/26/2008 | EP1696924B1 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 03/26/2008 | EP1684775B1 Use of extracts from the pelargonium species |
| 03/26/2008 | EP1613594B1 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 03/26/2008 | EP1573450A4 System and method for transparent early detection, warning, and intervention during a medical procedure |
| 03/26/2008 | EP1527075B1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 03/26/2008 | EP1490037B1 Taste masked veterinary solid compositions |
| 03/26/2008 | EP1467997B1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 03/26/2008 | EP1439179B1 New oripavine derivatives and their uses as medicines |
| 03/26/2008 | EP1434053B1 Reagent for detecting risk factor for alzheimer's disease, detection kit therefor and method of detecting risk factor for alzheimer's disease using the same |
| 03/26/2008 | EP1296671B1 Gabapentin analogues for sleep disorders |
| 03/26/2008 | EP1289527B1 (+)-alpha-(2,3-dimethoxyphenyl)-1(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol or its prodrug to treat dementia or cognitive impairment |
| 03/26/2008 | EP1248847B1 Irak-4: compositions and methods of use |
| 03/26/2008 | EP0917535B1 Neuroactive peptide |
| 03/26/2008 | CN101151376A Method for study, determination or evaluation |
| 03/26/2008 | CN101151274A ROR alpha for promoting the induction of Bmal1 expression |
| 03/26/2008 | CN101151051A Analgesic combination of sodium channel blockers with opioid antagonists |
| 03/26/2008 | CN101151034A Meninges nerve cell protector containing prostaglandin F2alpha derivative as effective component |
| 03/26/2008 | CN101151031A Tricyclic cytoprotective compounds |
| 03/26/2008 | CN101151026A O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof |
| 03/26/2008 | CN101147782A Tongqiao cerebral throbosis pain-relieving pestilence-curing ling |
| 03/26/2008 | CN101147781A Externally-applied medicine for treating migraine pain |
| 03/26/2008 | CN101147773A Medicine for treating neurasthenia |
| 03/26/2008 | CN101147761A Traditional Chinese medicine prescription for treating peripheral facial paralysis and making method |
| 03/26/2008 | CN101147741A Medicine for giving up drug |
| 03/26/2008 | CN101147739A Composition containing rotigotine and its use and transdermal patch containing the composition |
| 03/26/2008 | CN101147737A Selective estrogenic receptor subtype regulator and its synthesizing method and medical use |
| 03/26/2008 | CN101147735A Pharmaceutical composition for injection and its medicine box |
| 03/26/2008 | CN101147731A Tramadol hydrochloride and paracetamol combined injection |
| 03/26/2008 | CN101147586A Health-care food for improving sleep |
| 03/26/2008 | CN100376581C [1,4]diazocino [7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents |
| 03/26/2008 | CN100376579C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and use in treating |
| 03/26/2008 | CN100376578C Indole group alkaloid of sector Gouyahua, and application for preparing drug-breaking medicine |
| 03/26/2008 | CN100376576C Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 03/26/2008 | CN100376575C [1,4]diazepino[6,7,1-ij]quinoline derivatives as anti psychotic and antiobesity agents |
| 03/26/2008 | CN100376573C 1,3-dihydroimidazole fused-ring compound |
| 03/26/2008 | CN100376571C 6-substituted pyrido-pyrimidines |
| 03/26/2008 | CN100376564C Substituted heterocyclic benzoeycloalkenes and the use thereof as substances having analgesic effect |
| 03/26/2008 | CN100376530C Vitamin D analogues |
| 03/26/2008 | CN100376270C Externally applied medicine ointment for treating Yin-icterus and bone Bi-syndrome and its preparation process |
| 03/26/2008 | CN100376260C Method for preparing Qingkailing preparation |
| 03/26/2008 | CN100376251C Freeze-dried preparation containing methylcobalamin and process for producing the same |
| 03/26/2008 | CN100376245C Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent |
| 03/25/2008 | US7348433 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction |
| 03/25/2008 | US7348431 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 03/25/2008 | US7348429 Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process |
| 03/25/2008 | US7348426 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 03/25/2008 | US7348400 α-conotoxin peptides with analgesic properties |
| 03/25/2008 | US7348359 Retinoid X receptor modulators |
| 03/25/2008 | US7348354 Cyclohexylurea compounds |
| 03/25/2008 | US7348353 Acetylene derivatives having mGluR 5 antagonistic activity |
| 03/25/2008 | US7348342 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent |
| 03/25/2008 | US7348341 Chemical compounds |
| 03/25/2008 | US7348340 "caused" by the stimulation of nociceptive receptors and transmitted over intact neural pathways; 2-(4-Chlorophenyl)-quinoline-4,6-diamine; acute, persistent and neuropathic pain |
| 03/25/2008 | US7348339 2-(4-amino-furazan-3-yl)-1-ethyl-N-[(2R)-2-morpholinylmethyl]-1H-imidazo[4,5-c]pyridine-7-carboxamide; Mitogen- and Stress-Activated Protein (MSK) and Rho (guanosine triphosphate) 1 or 2 kinase inhibitor; neurodegenerative diaeases; antiinflammatory, anticarcinogenic, antiviral and antibacterial agent |
| 03/25/2008 | US7348336 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 03/25/2008 | US7348335 Compositions useful as inhibitors of JAK and other protein kinases |
| 03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
| 03/25/2008 | US7348327 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 03/25/2008 | US7348326 in brain; (2,5-difluorodifluorophenyl)-N-methyl-N-((1-propylbenzimidazol-2-yl)methyl)carboxamide; anxiolitic and antidepressant; finding and altering the signal-transducing activity of gamma aminobutyric acid (GABA) receptors; detectably-labeled antagonist/agonist of GABAR |
| 03/25/2008 | US7348321 Flumazenil for the treatment of alcohol dependency |
| 03/25/2008 | US7348173 Fatty-acid amide hydrolase |
| 03/25/2008 | US7348138 Diagnostic methods and kits for identifying individuals exposed to West Nile virus or other viruses including Flavivirus or Pestivirus |
| 03/25/2008 | US7348031 Method for preparing colloidal particles in the form of nanocapsules |
| 03/25/2008 | US7348000 Therapeutic compositions and methods of treating glycolipid storage related disorders |
| 03/25/2008 | US7347995 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients |
| 03/25/2008 | CA2419077C A method of treating a systemic disease |
| 03/25/2008 | CA2385533C Polymer stabilized neuropeptides |
| 03/25/2008 | CA2370446C Pharmaceutical compounds |
| 03/25/2008 | CA2315835C New crystalline form of 1-methyl-5-p-toluoylpyrrole-2-acetamidoacetic acid guaiacyl ester |
| 03/25/2008 | CA2299308C Cyclohexenone long-chain alcohol and medicament containing same |
| 03/25/2008 | CA2268394C New heterocyclylmethyl-substituted pyrazol derivates |
| 03/25/2008 | CA2243578C High affinity nucleic acid ligands of complement system proteins |
| 03/25/2008 | CA2203652C A method of down-regulating gene expression |
| 03/25/2008 | CA2174707C Chromone derivatives as nk1 and substance p antagonists |
| 03/20/2008 | WO2008034087A2 Treating schizophrenia with combinations of levodopa and an antipsychotic agent |
| 03/20/2008 | WO2008034041A2 Therapeutic combinations |
| 03/20/2008 | WO2008034040A1 Topiramate compositions and methods for their use |
| 03/20/2008 | WO2008033764A2 Quinazolinone and isoquinolinone acetamide derivatives |
| 03/20/2008 | WO2008033757A2 2-(1-oxo-1h-isoquinolin-2-yl) acetamide derivatives |
| 03/20/2008 | WO2008033572A1 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 03/20/2008 | WO2008033468A2 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism |
| 03/20/2008 | WO2008033465A1 Azetidinone derivatives and methods of use thereof |
| 03/20/2008 | WO2008033299A2 Use of n-containing spirocompounds for the enhancement of cognitive function |
| 03/20/2008 | WO2008032764A1 Fused heterocyclic derivative |
| 03/20/2008 | WO2008032665A1 Novel phenylacetic acid derivative |
| 03/20/2008 | WO2008032204A1 Substituted pyridylmethyl bicyclocarboxyamide compounds |
| 03/20/2008 | WO2008032191A2 Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators |
| 03/20/2008 | WO2008031928A1 Use of milnacipran for reducing the rewarding properties of alcohol during or after an alcohol withdrawal treatment |
| 03/20/2008 | WO2008031888A2 Condensed pyrimidinones active on glutamatergic receptors |
| 03/20/2008 | WO2008031831A2 Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein |
| 03/20/2008 | WO2008031799A1 Use of piperazine compounds for the treatment of neurodegenerative diseases |
| 03/20/2008 | WO2008031788A1 Aminoazepine derivatives as highly efficient inhibitors of the inducible nitric oxide synthase |
| 03/20/2008 | WO2008031772A1 Azabicyclic compounds as inhibitors of monoamines reuptake |
| 03/20/2008 | WO2008031771A2 3-azabicyclo [4. 1. 0] heptane derivatives for the treatment of depression |
| 03/20/2008 | WO2008031734A1 5-phenyl-nicotinamide derivatives |